Jemperli (Dostarlimab)

Complete patient guide for uses, dosage, side effects, and safety information

Prescription Required

Quick Facts

Generic Name
Dostarlimab
Drug Class
Monoclonal antibody
Used For
Treatment of endometrial cancer
How Taken
Administered via intravenous infusion in a clinical setting

What Is Jemperli Used For?

Jemperli is a medication that contains the active ingredient dostarlimab, which is designed to help the immune system combat cancer.

Primary Uses

Jemperli is primarily used to treat endometrial cancer, particularly when the cancer has spread or cannot be surgically removed.

How It Works

Dostarlimab works by recognizing and attaching to specific targets in the body, thereby enhancing the immune response against cancer cells.

Good to know: Jemperli is not considered addictive.

Continue Reading

Sign in to access the complete medication guide including dosage, side effects, warnings, and more.

How to Take Jemperli

Jemperli is given under the supervision of a healthcare professional in a hospital or clinic setting.

Dosage Instructions

The recommended dosage is 500 mg every 3 weeks for the first 4 doses, followed by 1000 mg every 6 weeks for subsequent cycles. If given with chemotherapy, the initial dosage is 500 mg every 3 weeks for 6 doses.

What If You Miss a Dose?

If you miss a dose, contact your healthcare provider immediately to reschedule your appointment.

Important: Do not double the dose if you miss one.

Side Effects

Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.

Common Side Effects

These side effects occur relatively frequently and usually don’t require emergency care:

  • Anemia (decrease in red blood cells)
  • Low thyroid hormone levels
  • Diarrhea
  • Nausea
  • Vomiting
  • Rash
  • Itchy skin
  • Fever
  • Increased liver enzyme levels

Seek immediate medical attention if you experience:

  • Inflammation of the lungs (shortness of breath, chest pain, cough)
  • Inflammation of the digestive tract (trouble swallowing, decreased appetite, severe stomach pain)
  • Inflammation of the liver (nausea, loss of appetite, yellowing of skin or eyes)
  • Inflammation of hormone glands (rapid heartbeat, weight changes, increased sweating)
  • Inflammation of the kidneys (changes in urine, swelling, blood in urine)
  • Infusion-related reactions (shortness of breath, rash, dizziness)
  • Serious complications in organ transplant patients

Important Warnings

There are several important considerations to keep in mind when using Jemperli.

Who Should Not Take Jemperli

Do not use Jemperli if you have a known allergy to dostarlimab or any of its ingredients.

Medical Conditions to Discuss

Inform your doctor if you have any immune system issues, lung or breathing problems, liver or kidney conditions, or any serious rashes.

Pregnancy and Breastfeeding

Jemperli should not be used during pregnancy unless specifically recommended by your doctor. Effective contraception is advised during treatment and for at least 4 months after the last dose. Do not breastfeed during treatment and for at least 4 months after.

Drug Interactions

Some medications may interfere with how Jemperli works.

  • Corticosteroids
  • Other medications affecting the immune system

Alcohol & Driving

Be cautious with alcohol and driving while taking Jemperli.

Alcohol

Consult your doctor regarding alcohol consumption while on Jemperli.

Driving and Operating Machinery

Jemperli is unlikely to impair your ability to drive, but be cautious if you experience side effects that affect concentration.

Storage

Jemperli should be stored in a refrigerator at temperatures between 2°C to 8°C and will be administered in a clinical setting.

Overdose Information

In case of an overdose, seek immediate medical attention.

Frequently Asked Questions

The time it takes for Jemperli to show effects can vary based on individual response and the specific cancer being treated.

There are no specific instructions regarding food interactions with Jemperli.

No, Jemperli is not considered addictive.

Do not stop taking Jemperli suddenly without consulting your doctor, as this may affect your treatment.

Consult your doctor regarding alcohol consumption while on Jemperli.

Weight gain is not specifically mentioned as a side effect of Jemperli.

Elderly patients should discuss their overall health and any specific concerns with their doctor before starting Jemperli.

Important Disclaimer

This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.

If you think you may have a medical emergency, call your doctor or emergency services immediately.

Create a free account to access the full medication guide.

Sign in to access your medication guides.